Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. Evidence for a common mechanism

• Published in: The Journal of biological chemistry Vol. 262; no. 14; pp. 6615 - 6622
• Main Authors: Bjorge, J D, Kudlow, J E
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Elsevier Inc 15.05.1987; American Society for Biochemistry and Molecular Biology
• Subjects: Biological and medical sciences; Breast Neoplasms; Cell Line; Cell receptors; Cell structures and functions; Epidermal Growth Factor - pharmacology; ErbB Receptors - biosynthesis; ErbB Receptors - drug effects; ErbB Receptors - metabolism; Female; Fundamental and applied biological sciences. Psychology; Humans; Kinetics; Molecular and cellular biology; Tetradecanoylphorbol Acetate - pharmacology; Human origin; Vertebrata; Membrane receptor; Epidermal growth factor; Mammalia; Mouse; Animal; Rodentia; Established cell line; Activation; Biosynthesis; Mechanism of action
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/S0021-9258(18)48286-5

Previously, we and others have shown that epidermal growth factor (EGF) stimulates the synthesis of its own receptor and the accumulation of EGF receptor mRNA. Here, we demonstrate that the tumor promotor, 12-O-tetradecanoylphorbol-13-acetate (TPA), like EGF, also stimulates receptor synthesis in the human breast carcinoma cell line, MDA468 cells. The receptor synthesis rate increased 5-fold with a peak at 8 h after exposure to TPA with half-maximal stimulation at a dose of 5 ng/ml TPA. This stimulation of receptor synthesis occurred despite a 30% decrease in general cellular protein synthesis. The increased receptor synthesis rate resulted in the accumulation of 60% more receptor protein as determined by quantitative immunoblotting using a newly developed monoclonal antibody, H9B4. Although TPA treatment resulted in an immediate loss of high affinity EGF-binding sites, the long-term effect was an increase in both the low and high affinity binding sites. The effects of EGF and TPA on receptor synthesis were not additive. Furthermore, down-regulation of protein kinase C (the Ca2+/phospholipid-dependent enzyme) by long-term TPA treatment resulted in cells unable to respond to the stimulatory effects of both TPA and EGF on receptor synthesis. Nevertheless, the TPA-pretreated cells were still growth-inhibited by EGF. These results suggest that the stimulatory effect of EGF on receptor synthesis requires protein kinase C, whereas the inhibitory effect of EGF on the proliferation of these cells does not. Although we confirmed that EGF stimulated the incorporation of phosphate into phosphatidylinositol in A431 cells, it failed to do so in the MDA468 cells. Thus, in MDA468 cells, EGF may require protein kinase C for part of its action, but we could not demonstrate an associated activation of phosphatidylinositol turnover by EGF. The exact mechanism of involvement of protein kinase C in EGF action is still not clear.